Changes in the ageing brain in health and disease
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The brains of individuals, who are cognitively normal, show age–related changes that include an overall reduction in brain volume and weight, which are associated with gyral atrophy and widening of the sulci of the cerebral cortex, and enlargement of the brain ventricles. These changes are partly the result of nerve cell loss but accurate estimates of neuronal loss are notoriously difficult to make. Microscopically, there are increasing amounts of the age–related pigment, lipofuscin, granulovacuolar degeneration in neurons, Hirano bodies, variable amounts of diffuse deposits of β–amyloid in the parenchyma, the presence of neurofibrillary tangles mainly confined to the hippocampus and amygdala, and sparse numbers of senile plaques in these brain regions and also in other cortical areas. Of these changes, neurofibrillary tangles and senile plaques are the neuropathological hallmark of Alzheimer's disease in which they are more abundant and widespread. Alzheimer's disease has therefore been regarded as accelerated brain ageing; however, the realization that there is a strong genetic contribution to developing the disease at least implies that it may not be the inevitable, even if frequent, consequence of old age. Understanding the molecular basis of plaque and tangle formation is advancing greatly and is the main focus of research into the cellular and molecular changes observed in the ageing brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · cited 1×
“…compared to Ab40, as do cells transfected with mutant presenilins, and plasma from Alzheimer's patients possessing mutant presenilins also has relatively more Ab42 as do the brains from transgenic mice expressing such mutant presenilins (Scheuner et al. 1996; Du¡ et al. 1996; Borchelt et al. 1996).”
BackgroundAlzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 1×
“Most notably, mice transgenic for an APP minigene with one of the APP717 mutations develop neuritic plaques remarkably similar to those typical of Alzheimer's disease (Games et al. 1995).”
BackgroundBorchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363 · cited 1×
“Apolipoprotein E4 protein has been claimed to promote aggregation of Ab more strongly than apolipoprotein E3 (Strittmatter et al. 1993), but other studies have found the opposite e¡ect and this may depend upon the source of apolipoprotein E used for the experiments (LaDu et al. 1994).”
BackgroundGoedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., & Crowther, R. A. (1996) · Nature · doi:10.1038/383550a0 · Cited by 1,036 · cited 1×
“…become `frozen' in a hyperphosphorylated state with phosphatases no longer able to remove phosphate, possibly because of aggregation of the tau into PHF which might be triggered by generation of a truly abnormally phosphorylated site or by factors such as proteoglycans (Goedert et al. 1996).”
BackgroundRelease of Excess Amyloid β Protein from a Mutant Amyloid β Protein Precursor
Cai, X.-D., Golde, T. E., & Younkin, S. G. (1993) · Science · doi:10.1126/science.8424174 · Cited by 913 · cited 1×
“…of APP at the three secretase sites, and indeed experimental studies using transfected cells has shown that the Swedish double mutation results in a 5^8 fold increase in secreted Ab (Cai et al. 1993) and the APP717 mutations result in an increase in the ratio of Ab42 : Ab40 (Suzuki et al. 1994).”
BackgroundNeuron numbers and dendritic extent in normal aging and Alzheimer’s disease
Coleman, P. D., & Flood, D. G. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90127-8 · Cited by 772 · cited 1×
“The evidence suggests, however, that there is dendritic growth in the normal ageing brain and that this may be a compensatory mechanism for neuronal loss (Coleman & Flood 1987).”
BackgroundHanger, D. P., Hughes, K., Woodgett, J. R., Brion, J.-P., & Anderton, B. H. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90774-2 · Cited by 737 · cited 1×
“…state of tau similar to PHF-tau, as assessed by a marked decrease in electrophoretic mobility and reactivity with a panel of monoclonal antibodies speci¢c for phosphorylated epitopes present in PHF-tau, but not found in normal postmortem brain tau (Mandelkow et al. 1992; Hanger et al. 1992).”
BackgroundSelf-citationAPOLIPOPROTEIN E ALLELES AS RISK FACTORS IN ALZHEIMER'S DISEASE
Roses, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.387 · Cited by 707 · cited 1×
“Most Alzheimer's disease is late onset but it is now clear that much late onset Alzheimer's disease is associated with possession of the apolipoprotein e4 allelic form of the apolipoprotein (Roses 1996).”
Backgroundβ-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding
Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595 · cited 2×
“Two groups have claimed that treatment of cultured neurones with Ab leads to increased tau phosphorylation (Busciglio et al. 1995; Takashima et al. 1996), although work in our laboratory has failed to con¢rm such observations (Davis et al. 1995).”
BackgroundResultProline-directed and non-proline-directed phosphorylation of PHF-tau
Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Titani, K., & Ihara, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.823 · Cited by 557
Isoform-specific binding of apolipoprotein E to beta-amyloid.
LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31529-6 · Cited by 540
Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau
Mandelkow, E.-M., Drewes, G., Biernat, J., Gustke, N., Van Lint, J., Vandenheede, J. R., & Mandelkow, E. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81496-9 · Cited by 515 · cited 2×
“…state of tau similar to PHF-tau, as assessed by a marked decrease in electrophoretic mobility and reactivity with a panel of monoclonal antibodies speci¢c for phosphorylated epitopes present in PHF-tau, but not found in normal postmortem brain tau (Mandelkow et al. 1992; Hanger et al. 1992).”
BackgroundMann, D. M. A., & Esiri, M. M. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90019-1 · Cited by 471 · cited 1×
“However, examination of the brains from younger Down's syndrome cases has shown that di¡use Ab deposits occur in the late teens but neuritic plaques and tangles do not appear until 20 years later (Mann & Esiri 1989).”
BackgroundBraak, H., Braak, E., Grundke-Iqbal, I., & Iqbal, K. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90288-0 · Cited by 432 · cited 2×
“Ultrastructurally and immunocytochemically, they have been shown to be essentially the same as the PHF found in neuro¢brillary tangles and in the dystrophic neurites of neuritic plaques (Braak et al. 1986, 1994).”
BackgroundTakashima, A., Noguchi, K., Michel, G., Mercken, M., Hoshi, M., Ishiguro, K., & Imahori, K. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12257-5 · Cited by 260 · cited 1×
“Two groups have claimed that treatment of cultured neurones with Ab leads to increased tau phosphorylation (Busciglio et al. 1995; Takashima et al. 1996), although work in our laboratory has failed to con¢rm such observations (Davis et al. 1995).”
ResultAlzheimer’s disease after remote head injury: an incidence study
Schofield, P. W., Tang, M., Marder, K., Bell, K., Dooneief, G., Chun, M., Sano, M., Stern, Y., & Mayeux, R. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.2.119 · Cited by 260
In vivo phosphorylation sites in fetal and adult rat tau
Watanabe, A., Hasegawa, M., Suzuki, M., Takio, K., Morishima-Kawashima, M., Titani, K., Arai, T., Kosik, K. S., & Ihara, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74447-0 · Cited by 231
Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion
Nitsch, R. M., Deng, M., Growdon, J. H., & Wurtman, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4188 · Cited by 219 · cited 1×
“…it has been demonstrated by many laboratories that APP metabolism is modulated by activation of protein kinase C (PKC) (Efthimiopoulos et al. 1994; Nitsch et al. 1996; Govoni et al. 1996a), it may be timely to investigate the possible links between APP metabolism and tau phosphorylation that are…”
BackgroundLovestone, S., Hartley, C. L., Pearce, J., & Anderton, B. H. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00126-1 · Cited by 201
Self-citationMicrotubule bundling by tau proteins in vivo: analysis of functional domains
Kanai, Y., Chen, J., & Hirokawa, N. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05489.x · Cited by 194
Differential Binding of Apolipoprotein E Isoforms to Tau and Other Cytoskeletal Proteins
Fleming, L. M., Weisgraber, K. H., Strittmatter, W. J., Troncoso, J. C., & Johnson, G. V. W. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0064 · Cited by 82 · cited 1×
“Similarly, it has been proposed that apolipoprotein E3 binds tau more strongly than apolipoprotein E4 and may therefore protect tau from hyperphosphorylation (Fleming et al. 1996).”
BackgroundLatimer, D. A., Gallo, J.-M., Lovestone, S., Miller, C. C. J., Hugh Reynolds, C., Marquardt, B., Stabel, S., Woodgett, J. R., & Anderton, B. H. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00434-b · Cited by 48
Self-citation
Cited by
von Bartheld, C. S., Bahney, J., & Herculano‐Houzel, S. (2016) · Journal of Comparative Neurology · doi:10.1002/cne.24040 · Cited by 1,063
“…Fall-Out”, Brody, 1955; Hanley, 1974; Devaney and Johnson, 1980; Curcio et al., 1982) has been refuted, primarily through Haug’s pioneering work and others’ (Haug et al., 1984; Haug, 1987; Terry et al., 1987; West, 1993b; Anderton, 1997; see also “Examples showing impact of cell counting,” below).”
BackgroundValenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L., & Cellerino, A. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.038 · Cited by 784
Longitudinal pattern of regional brain volume change differentiates normal aging from MCI
Driscoll, I., Davatzikos, C., An, Y., Wu, X., Shen, D., Kraut, M., & Resnick, S. M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a82634 · Cited by 532
Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease
Harding, A. J., Stimson, E., Henderson, J. M., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf251 · Cited by 443
Facial expression recognition across the adult life span
Calder, A. J., Keane, J., Manly, T., Sprengelmeyer, R., Scott, S., Nimmo-Smith, I., & Young, A. W. (2003) · Neuropsychologia · doi:10.1016/s0028-3932(02)00149-5 · Cited by 390
Metadata
- Authors
- Anderton, B. H.
- Venue
- Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 1997-12-29
- Volume
- 352
- Issue
- 1363
- Pages
- 1781-1792
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2096547809
- Cited by
- 77
- References
- 26
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.